Location History:
- Westminister, CO (US) (2014)
- Westminster, CO (US) (2014 - 2017)
Company Filing History:
Years Active: 2014-2017
Title: Innovations in Diabetes Therapy by Richard J Gorczynski
Introduction
Richard J Gorczynski is a notable inventor based in Westminster, CO (US). He has made significant contributions to the field of diabetes therapy, holding a total of 3 patents. His work focuses on enhancing glycemic control and insulin sensitivity in diabetic patients, particularly those with complications such as diabetic nephropathy and metabolic syndrome.
Latest Patents
Gorczynski's latest patents include innovative methods for treating diabetes-related complications. One of his patents describes a method for enhancing glycemic control and insulin sensitivity in human subjects suffering from diabetic nephropathy and/or metabolic syndrome. This method involves administering a selective endothelin A (ET) receptor antagonist in an effective amount. Another patent outlines a treatment for elderly diabetic patients with comorbidities, which combines a selective ET receptor antagonist with at least one additional agent effective in treating diabetes and related conditions. Additionally, he has developed a therapeutic combination that includes a selective ET receptor antagonist and at least one antidiabetic, anti-obesity, or antidyslipidemic agent.
Career Highlights
Richard J Gorczynski is currently associated with AbbVie Deutschland GmbH & Co. KG, where he continues to advance his research and innovations in diabetes therapy. His work has been instrumental in developing new treatment options for patients facing complex health challenges due to diabetes.
Collaborations
Gorczynski has collaborated with notable colleagues, including Robert L Roden and Michael J Gerber, to further enhance the impact of his research and innovations in the field of diabetes treatment.
Conclusion
Richard J Gorczynski's contributions to diabetes therapy through his innovative patents and collaborations highlight his commitment to improving patient outcomes. His work continues to pave the way for advancements in the treatment of diabetes and its complications.